Manufacturing Chemist Stand Side with C2 Pharma

Published: 6-Nov-2023 Featured companies: C-squared Pharma
Manufacturing Ingredients Marketing

At the recent CPHI WorldWide event in Barcelona, Spain, CEO of C2 Pharma, Andrew Badrot, talked exclusively to Manufacturing Chemist Stand Side

As well as covering a range of topics, from staying ahead of the competition to fostering a culture of quality, Andrew also took a crystal ball approach to what's happening in the industry. He talked about trends and upcoming innovations, how they will impact how the company operates ... and what customers can expect from C2 Pharma in 2024.

Manufacturing Chemist Stand Side...

'Manufacturing Chemist Stand Side' is a series of exclusive video interviews with leading companies in the pharmaceutical industry, conducted during key market events by our award-winning B2B team.

For more information on how you can be part of 'Manufacturing Chemist Stand Side' contact Don Phares on +44 207 193 3219 or via email: don@hpcimedia.com.

Featured companies

C2 PHARMA is an European pharmaceutical group established in 2014. It manufactures and distributes active pharmaceutical ingredients (APls) and complex chemical compounds...
See more

You may also like

Manufacturing

C2 PHARMA marks 10 years at CPHI Milan with expanded ophthalmic APIs

Read more
The complany is ready to showcase its expanding ophthalmic API portfolio and global regulatory filings, featuring Naphazoline Hydrochloride and Tropicamide

Trending Articles

  1. IMA Life and RheaVita team up to commercialise continuous biopharmaceutical freeze-drying tech The companies will work in tandem to develop and commercialise its continuous freeze-drying technology, allowing the rapid production of complex biopharmaceuticals
  2. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  3. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  4. How flow chemistry is transforming drug discovery New Syrris eBook explores techniques driving efficiency and innovation
  5. Adragos Pharma enhances its sterile injectable production capabilities with new €13m ampoule filling line The novel line at the CDMO's Livron-sur-Drôme site in France will allow the company to manufacture more than 160 million ampoules for sterile injectables annually

Relevant companies

See more

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

C2 PHARMA marks 10 years at CPHI Milan with expanded ophthalmic APIs

The complany is ready to showcase its expanding ophthalmic API portfolio and global regulatory filings, featuring Naphazoline Hydrochloride and Tropicamide
Ingredients

C2 PHARMA expands ophthalmic API portfolio with Naphazoline Hydrochloride launch

C2 PHARMA, the global leader in ophthalmic and niche active pharmaceutical ingredients (APIs), proudly announces the launch of its latest API, Naphazoline Hydrochloride
Ingredients

C2 PHARMA announces upcoming launch of new oxybuprocaine hydrochloride API

C2 PHARMA excited to announce the upcoming launch of its new API, oxybuprocaine HCL, an ingredient that will be manufactured by manufacturing partner Laurus Labs
Ingredients

C2 Pharma to participate in DCAT Week 2024

The C2 PHARMA team will be located in the Benjamin hotel in Suite 2202
Ingredients

C2 PHARMA receives DMF approval in China for pilocarpine nitrate

C2 PHARMA announces the approval of a C-DMF for pilocarpine nitrate — granted on 30 October 2023 — an API manufactured by our Brazilian partner Anidro do Brasil
Ingredients

C2 PHARMA expands API portfolio with global regulatory access ahead of CPHI Barcelona

C2 PHARMA along with their affiliates, Logistics4PHARMA and ASM Research Chemicals, will be exhibiting in the Integrated Pharma Hall for the first time at booth 4D49
Manufacturing

C2 Pharma focuses on ophthalmic APIs at CPHI

Located at stand 4D49, the company looks forward to informing customers about its expanded logistics facility in Frankfurt and what its unique DEV Pack approach can do to streamline API processes
Subscribe now